about
N-chloramines, a promising class of well-tolerated topical anti-infectivesAlleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory DrugsIn vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa.Influence of amphotericin B on the ciliary beat frequency of nasal mucosa.A novel N-chlorotaurine-corticosteroid combination as a preservative-free local disinfectant: influence on the ciliary beat frequency in vitro.Tolerability of inhaled N-chlorotaurine in the pig modelImpact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp.Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.N-chlorotaurine, a long-lived oxidant produced by human leukocytes, inactivates Shiga toxin of enterohemorrhagic Escherichia coliBactericidal activity of herbal extracts.In vitro activity of N-chlorotaurine (NCT) in combination with NH4Cl against Trichomonas vaginalis.Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains.N-chlorotaurine, a natural antiseptic with outstanding tolerability.Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.Bactericidal activity of N-chlorotaurine against biofilm-forming bacteria grown on metal disksAcanthamoeba castellanii : growth on human cell layers reactivates attenuated properties after prolonged axenic culture.N-Chlorotaurine shows high in vitro activity against promastigotes and amastigotes of Leishmania species.Basidiomycete metabolites attenuate virulence properties of Candida albicans in vitro.Comparative Analysis of Microbicidal and Anti-inflammatory Properties of Novel Taurine Bromamine Derivatives and Bromamine T.Pseudomonas aeruginosa outcompetes other bacteria in the manifestation and maintenance of a biofilm in polyvinylchloride tubing as used in dental devices.The Integral Method, a new approach to quantify bactericidal activity.Activity of N-chlorotaurine against herpes simplex- and adenoviruses.N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.Microbial contamination of glaucoma eyedrops used by patients compared with ocular medications used in the hospitalBreath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study.Cytotoxic activity of N-chlorotaurine on Acanthamoeba sppMicrobicidal activity of N-chlorotaurine in combination with hydrogen peroxideAntimicrobial and anticoagulant activities of N-chlorotaurine, N,N-dichloro-2,2-dimethyltaurine, and N-monochloro-2,2-dimethyltaurine in human bloodReassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte.Protein sites of attack of N-chlorotaurine in Escherichia coli.Active halogen compounds and proteinaceous material: loss of activity of topical anti-infectives by halogen consumption.Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system.Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study.Tolerability of N-chlorotaurine in the guinea pig middle ear: a pilot study using an improved application system.Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent.Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.Antibacterial activity of mometasone furoate.Tolerability of N-chlorotaurine in the bovine mammary gland.Inactivation of microbicidal active halogen compounds by sodium thiosulphate and histidine/methionine for time-kill assays.Comparison of the Microbicidal activity of monochloramine and iodine.
P50
Q24609416-2BABD404-D6BC-422E-9EE9-CA5EE91FDB8FQ30234292-EEE0D945-8740-40FA-BA3F-3D98A2C45D98Q31149712-DC0C96DE-B03F-4193-9C19-655A8B661CB7Q33208424-6E9D7FFC-D2C9-4F0F-A9E6-14E56A8386E5Q33240094-B94B1CC2-8A59-44E7-8FBF-6D5A4B82868DQ33481958-8A0AD93C-1075-4316-8E4A-773DBBEBB657Q34108727-81BBBB92-A5A3-47F5-8669-EC847613B731Q34310915-3ADF96F7-17FB-43D8-B958-B5A021CD1AEFQ34471784-31FAED0A-17B7-4E94-B75D-D6A223FB09B5Q34535637-4914F3D7-74EF-4A70-9710-2B4E33136736Q34538799-BD2190CD-5176-416E-AC89-C28A9C2B4CC8Q35746085-5671AC5C-DFBC-42C3-BDEE-B91B1D7DEEE9Q37669557-37EE4A8F-FFB0-4A77-BDDE-102C75FF25F6Q38554220-6CCD40B0-9A61-429A-A4C0-684E338E701DQ39257255-4E36C88F-81BC-4580-9E0F-13B797493669Q39803453-250992FF-EF86-43CF-B166-ED7A829FF199Q39835488-80FBDE27-0E27-4D91-A1B6-95E15FA703CAQ39990721-C33A39EF-7019-43E0-9D7D-406300DFA570Q40076352-C74A91C0-3EF5-4290-A0BB-88A2E942D36DQ40257518-EA9AA7C5-78B9-4EF4-9C70-CB340022104FQ40957622-328F9292-E5F0-4537-BCFA-0DA7018EA4BBQ41037196-9DCA92A4-2422-4096-BD58-4874E358FBC4Q41073674-6B0E44CD-E0CA-4A7E-BE16-CFE07AE02339Q41349805-49343A5B-107B-4D49-81A4-3311C2DDAD3FQ41564264-CE86227B-0156-41F5-BB4A-CD33754B95EBQ41915150-9C3A8E01-FF82-417E-8670-BC9A2685F406Q42123143-DDDFD171-FF8C-4D73-AB0B-5A234837DE81Q42558982-34B8B60C-96D7-433B-AC16-126A5B2A846BQ43187504-E56DACA8-D1CE-4596-A335-52BC6858B532Q43639257-C91D8625-9A2E-4BD9-80F4-B5F80E5E9F97Q43848061-A3A376B4-3141-4555-9807-6B05B34DEB3BQ44226784-D3D00C9C-AADE-4556-A299-463EFAF71059Q44597171-432FD0EE-ABE9-4849-A916-D1C5B83E5F67Q44756151-A67E2B42-DF3C-42AB-84E1-C4922E2E650AQ44883434-B10A7ABA-1704-4EFF-AC8B-D65E4FB0F312Q45746650-B8671465-D704-4B71-8F7B-162B83E77A6BQ46587356-D91F984F-5BF6-46E9-81CC-9952A731F246Q46599817-043A9954-76C4-4171-91BD-E866E465C453Q50515639-0D3AEAF9-21C2-4592-BE91-87920814B298Q50793833-65F093BA-BA01-498F-9CD8-C9DE0A184817
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Markus Nagl
@ast
Markus Nagl
@en
Markus Nagl
@es
Markus Nagl
@nl
Markus Nagl
@sl
type
label
Markus Nagl
@ast
Markus Nagl
@en
Markus Nagl
@es
Markus Nagl
@nl
Markus Nagl
@sl
prefLabel
Markus Nagl
@ast
Markus Nagl
@en
Markus Nagl
@es
Markus Nagl
@nl
Markus Nagl
@sl
P106
P21
P31
P496
0000-0002-1225-9349